Larry E. Weaner

427 total citations
19 papers, 359 citations indexed

About

Larry E. Weaner is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Larry E. Weaner has authored 19 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Larry E. Weaner's work include Analytical Chemistry and Chromatography (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Chemical Reactions and Isotopes (4 papers). Larry E. Weaner is often cited by papers focused on Analytical Chemistry and Chromatography (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Chemical Reactions and Isotopes (4 papers). Larry E. Weaner collaborates with scholars based in United States and Romania. Larry E. Weaner's co-authors include Timothy C. Kiorpes, Gene F. Tutwiler, Winston Ho, Frank J. Villani, Samuel Nortey, Aurora Molinari, Leonard R. Hecker, Michael J. Costanzo, William Leister and John P. Jasper and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Analytical Biochemistry.

In The Last Decade

Larry E. Weaner

18 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry E. Weaner United States 8 187 86 81 40 38 19 359
Einārs Loža Latvia 13 283 1.5× 60 0.7× 63 0.8× 85 2.1× 23 0.6× 23 436
Toshio Muramatsu Japan 14 211 1.1× 86 1.0× 52 0.6× 20 0.5× 27 0.7× 25 444
Shirley Cheng United States 12 196 1.0× 38 0.4× 19 0.2× 43 1.1× 41 1.1× 33 399
R. Tonani Italy 9 187 1.0× 137 1.6× 157 1.9× 44 1.1× 38 1.0× 19 447
Hoyan S. She United States 11 268 1.4× 73 0.8× 17 0.2× 64 1.6× 24 0.6× 18 482
Roland P.‐T. Chung Australia 13 177 0.9× 105 1.2× 34 0.4× 45 1.1× 32 0.8× 24 433
T. A. Trendeleva Russia 12 242 1.3× 27 0.3× 17 0.2× 48 1.2× 22 0.6× 20 344
Renate Untucht‐Grau Germany 7 382 2.0× 35 0.4× 53 0.7× 44 1.1× 26 0.7× 9 562
Mitsune Yamaguchi Japan 9 118 0.6× 25 0.3× 22 0.3× 22 0.6× 9 0.2× 14 334
L. Stuhne-Sekalec Canada 13 301 1.6× 17 0.2× 72 0.9× 26 0.7× 27 0.7× 52 461

Countries citing papers authored by Larry E. Weaner

Since Specialization
Citations

This map shows the geographic impact of Larry E. Weaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry E. Weaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry E. Weaner more than expected).

Fields of papers citing papers by Larry E. Weaner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry E. Weaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry E. Weaner. The network helps show where Larry E. Weaner may publish in the future.

Co-authorship network of co-authors of Larry E. Weaner

This figure shows the co-authorship network connecting the top 25 collaborators of Larry E. Weaner. A scholar is included among the top collaborators of Larry E. Weaner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry E. Weaner. Larry E. Weaner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lin, Ronghui, et al.. (2017). Syntheses of isotope‐labeled SGLT2 inhibitor canagliflozin (JNJ‐28431754). Journal of Labelled Compounds and Radiopharmaceuticals. 60(13). 616–623. 1 indexed citations
2.
Song, Fengbin, Rhys Salter, & Larry E. Weaner. (2015). A short synthesis of d‐[1‐14C]‐serine of high enantiomeric purity. Journal of Labelled Compounds and Radiopharmaceuticals. 58(4). 173–176. 3 indexed citations
3.
Lin, Ronghui, et al.. (2013). Expeditious syntheses of stable and radioactive isotope‐labeled anticonvulsant agent, JNJ‐26990990, and its metabolites. Journal of Labelled Compounds and Radiopharmaceuticals. 56(1). 22–26. 1 indexed citations
4.
Lin, Ronghui & Larry E. Weaner. (2012). Facile synthesis of stable isotope‐labeled antibacterial agent RWJ‐416457 and its metabolite. Journal of Labelled Compounds and Radiopharmaceuticals. 55(8). 296–299. 1 indexed citations
5.
Gong, Yong, et al.. (2008). Synthesis of [2H, 13C] and [14C] labeled vasopressin V1a/V2 receptor antagonist RWJ‐676070 and its stable labeled N‐des‐benzoyl metabolite. Journal of Labelled Compounds and Radiopharmaceuticals. 51(6). 268–272. 7 indexed citations
6.
Maroney, Anna C., Juan Marugán, Alexander N. Barnakov, et al.. (2006). Dihydroquinone Ansamycins:  Toward Resolving the Conflict between Low in Vitro Affinity and High Cellular Potency of Geldanamycin Derivatives. Biochemistry. 45(17). 5678–5685. 46 indexed citations
7.
Jasper, John P., et al.. (2005). A preliminary multi-stable-isotopic evaluation of three synthetic pathways of Topiramate. Journal of Pharmaceutical and Biomedical Analysis. 39(1-2). 66–75. 15 indexed citations
8.
Alaimo, Robert J., M.R. Evans, Hugh M. French, et al.. (2000). Minimization and management of wastes from biomedical research.. Environmental Health Perspectives. 108(suppl 6). 953–977. 14 indexed citations
9.
Walker, Donald G., et al.. (1997). Synthesis of tritium-labeled azaline B acetate. Journal of Labelled Compounds and Radiopharmaceuticals. 39(2). 147–157.
10.
Walker, Donald G., William Leister, & Larry E. Weaner. (1995). Synthesis of 1,1′‐carbonyldimidazole‐1‐14C and its use in preparing a methoxy(polyethylene)glycol semicarbazide linker. Journal of Labelled Compounds and Radiopharmaceuticals. 36(7). 661–669. 3 indexed citations
11.
Leister, William, Larry E. Weaner, & Donald G. Walker. (1995). Analysis and purification of modified methoxy(polyethylene glycol) compounds of similar molecular mass by high-performance liquid chromatography. Journal of Chromatography A. 704(2). 369–376. 11 indexed citations
12.
Weaner, Larry E., et al.. (1988). Separation of fatty acid ester and amide enantiomers by high-performance liquid chromatography on chiral stationary phases. Journal of Chromatography A. 437(1). 109–119. 8 indexed citations
13.
Villani, Frank J., Larry E. Weaner, Leonard R. Hecker, et al.. (1988). Improved Procedures for the Preparation of Cycloalkyl-, Arylalkyl-, and Arylthioureas. Synthesis. 1988(6). 456–459. 87 indexed citations
15.
Weaner, Larry E., et al.. (1986). Synthesis of carbon‐14‐labeled sodium palmoxirate and its coenzyme a ester. Journal of Labelled Compounds and Radiopharmaceuticals. 23(4). 355–369. 1 indexed citations
17.
Carson, John R., et al.. (1983). Synthesis of tritium labeled zomepirac. Journal of Labelled Compounds and Radiopharmaceuticals. 20(12). 1383–1394. 1 indexed citations
18.
Wu, W. N., et al.. (1980). The metabolism of zomepirac sodium. II. Isolation and identification of the urinary metabolites in rat, mouse, rhesus monkey, and man.. Drug Metabolism and Disposition. 8(5). 349–352. 16 indexed citations
19.
Mendelson, Wilford L., et al.. (1975). The preparation of 15N‐phenoxybenzamine. Journal of Labelled Compounds. 11(3). 349–353. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026